/State%20Street%20Corp_%20HQ%20building-by%20JHVEPhoto%20via%20iStock.jpg)
State Street has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
/Stryker%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Stryker has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Humana%20Inc_%20logo%20on%20building-by%20BalkansCat%20via%20iStock.jpg)
Humana has notably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
Lennox International has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
/Accenture%20plc%20buiding%20with%20logo-by%20JHVEPhoto%20via%20iStock.jpg)
Accenture has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Archer-Daniels-Midland has notably outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.
2 Mega-Cap Stocks to Own for Decades and 1 We Avoid